Celeste Krewson, Assistant Editor

A new study revealed that hybrid vaginal ovules, incorporating curcumin and miconazole nitrate, offer effective relief against Candida albicans, potentially revolutionizing treatment for vulvovaginal candidiasis with reduced dosing frequency and adverse effects.

Learn from Paige Meizlik, MD, MSTR, about the FDA's Fast Track Designation for nipocalimab, offering hope for addressing the critical unmet needs in treating fetal neonatal alloimmune thrombocytopenia and advancing maternal-fetal immunology research.

A recent study by Allara Health revealed statistics linking polycystic ovary syndrome to significant workplace productivity decline, underscoring the need for comprehensive care and heightened awareness among employers and providers.

Carolyn Kay, MD, discusses the latest ASCCP guidelines and the introduction of dual stain cytology for improved HPV detection and patient management, aiming to alleviate anxiety and enhance efficacy in cervical cancer prevention.

Delve into the complexities of primary pulmonary arterial hypertension, exploring its clinical manifestations, recommended management strategies, and the pressing need for further research, particularly in the context of pregnancy.

Shefali Mavani Shastri, MD, FACOG, addresses the complex intersection of cultural, religious, and medical factors affecting fertility treatment decisions among Muslim women during fasting holidays.

Explore the rising prevalence of sexually transmitted infections among young adults, the barriers to access proper testing, and the role of health care providers in destigmatizing sexual health discussions, as discussed by Jill S. Blumenthal, MD, associate professor of medicine at UC San Diego Health.

Discover the latest guidelines from the US Department of Health and Human Services, emphasizing the importance of informed consent in sensitive medical examinations, bolstering patient rights and trust.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Delve into the complex interplay between genital infections, antibiotic treatments, and the heightened risk of preterm birth, underscored by recent research findings in Antibiotics.

Cande Ananth, PhD, MPH, discusses a study exposing discrepancies in CDC maternal mortality data, highlighting errors in tracking methods and persistent racial disparities in maternal mortality rates.

Discover the need for improved evidence-based research on maternal vaccine safety, especially in underrepresented low-income settings, as highlighted by a recent study.

A recent study suggests that adherence to plant-based diets significantly decreases the risk of developing hypertensive disorders of pregnancy, shedding light on dietary interventions for maternal health.

A recent study unveiled the heightened risk of severe maternal morbidity associated with stillbirth, shedding light on crucial factors influencing maternal health outcomes.

A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.

Recent research highlights an association between cesarean delivery at full dilation and increased risk of subsequent preterm birth, prompting further investigation into childbirth practices and outcomes.

The FDA's Fast Track Designation for nipocalimab marks a significant step in addressing fetal neonatal alloimmune thrombocytopenia risk in pregnant patients, potentially revolutionizing treatment for this severe condition with unmet medical needs.

A recent study highlighted the link between residence in low-income areas with limited food access during pregnancy and increased risks of lower birth weight and small for gestational age infants, urging further investigation into potential interventions for improved birth outcomes.

A recent study examined the heightened risk of preterm birth associated with delayed loop electrosurgical excision procedure (LEEP) compared to immediate LEEP among women with cervical intraepithelial neoplasia grade 2.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Discover how a web-based decision aid significantly enhances the quality of tubal sterilization decision-making, offering crucial insights for marginalized populations, as revealed in a recent study.

A recent study dissected the relationships between maternal nativity, ethnicity, and race in influencing preterm birth rates, shedding light on disparities and suggesting avenues for future research.

A recent study delves into how neighborhood socioeconomic factors affect miscarriage and live birth rates post- in vitro fertilization across diverse racial populations, not finding a correlation with neighborhood-level socioeconomic factors.

Recent research reveals a stark decline in global fertility rates, with 76% of countries projected to fall below the population-sustaining threshold by 2050, prompting urgent calls for policy interventions to address demographic shifts.

GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.

A recent study exposed disparities in contraceptive counseling and use among hypertensive individuals, suggesting a need for tailored contraceptive options, particularly within Black communities.

Discover how FemaSeed, an innovative artificial insemination device by Femasys Inc, offers safe and effective fertility solutions through precise sperm delivery into the fallopian tube.

A recent study revealed Medicaid patients encounter significant obstacles to postpartum sterilization, shedding light on crucial health care access issues.

Delve into the implications of a study investigating maternal mortality tracking methods in the United States, as OB Hospitalist Group's Chief Medical Officer, Mark Simon, MD, highlights critical factors often overlooked and emphasizes collaborative care for preventing deaths.

Bayer's OASIS 3 trial affirmsed the safety and efficacy of elinzanetant in reducing moderate to severe vasomotor symptoms, bolstering confidence in its potential as a non-hormonal solution for menopause-related issues.